Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma.
Lymphoma
bendamustine
hematopoietic stem cell transplantation
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
pubmed:
16
2
2021
medline:
20
7
2021
entrez:
15
2
2021
Statut:
ppublish
Résumé
We evaluate the safety of bendamustine as a bridge to stem cell transplantation (SCT) in patients with relapsed/refractory lymphoma and residual disease after salvage therapy. Thirty-four subjects without complete responses (CR) received bendamustine 200 mg/m
Identifiants
pubmed: 33586581
doi: 10.1080/10428194.2021.1881516
doi:
Banques de données
ClinicalTrials.gov
['NCT02059239']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM